skip to main content
Opens in a new window Opens an external site Opens an external site in a new tab
When autocomplete results are available use up and down arrows to review and enter to select.
Belmore Neidrauer LLP Logo
  • About
    • Our Firm
    • Expertise
      • Patent Litigation
      • Patent Opinion
      • Trademark Litigation and Opposition
    • News
    • Awards
    • Diversity, Equity and Inclusion
    • Contact
  • Team
    • Marian Wolanski
    • Megan Pocalyuko
    • Andrew Medico
    • Mary Mutchler
    • Anna Hucman
  • Cases
  • IP Insights
Open search
  • Join us on LinkedIn
Contact
Home | Sitemap
  • About
    • Our Firm
    • Expertise
      • Patent Litigation
      • Patent Opinion
      • Trademark Litigation and Opposition
    • News
      • Want to Join Belmore Neidrauer? (5/14/2026 3:42:21 PM)
      • Marian Wolanski Recognized by Benchmark Litigation Canada 2026! (5/1/2026 6:08:14 PM)
      • LEXPERT® recognizes Marian Wolanski! (3/24/2026 8:35:51 PM)
      • Chambers Patent Litigation 2026 (3/3/2026 9:30:22 PM)
      • Belmore Neidrauer Recognized by Managing IP! (2/11/2026 8:17:50 PM)
      • The 18th Annual Harold G. Fox Moot (2/9/2026 5:00:00 AM)
      • Belmore Neidrauer Recognized by Chambers and Partners (2/9/2026 5:00:00 AM)
      • Marian Wolanski will be speaking at the 14th Annual University of Toronto Patent Colloquium! (11/13/2025 9:45:53 PM)
      • Belmore Neidrauer recognized by Best Law Firms™ – Canada (10/30/2025 6:08:29 PM)
      • Pharmascience Inc. v Janssen Inc. (Supreme Court File No. 41209) (10/16/2025 7:00:00 PM)
      • LMG Life Sciences Rankings 2025! (10/16/2025 1:43:09 PM)
      • Belmore Neidrauer recognized in Chambers 2026 (10/16/2025 1:40:09 PM)
      • Belmore Neidrauer recognized in the 20ᵗʰ edition of Best Lawyers™ (10/16/2025 1:38:04 PM)
      • LMG Life Sciences Awards: Americas 2025 (9/5/2025 3:28:12 PM)
      • LMG Life Sciences recognizes Belmore Neidrauer (9/5/2025 3:23:43 PM)
      • Belmore Neidrauer Shortlisted for 2025 LMG Life Sciences Americas Awards (7/3/2025 6:18:29 PM)
      • Belmore Neidrauer Recognized by Managing IP! (6/30/2025 6:19:06 PM)
      • Managing IP recognizes Marian Wolanski as a 2025 Patent Star! (6/3/2025 8:31:41 PM)
      • IAM Patent 1000 recognizes Belmore Neidrauer! (5/29/2025 10:27:30 PM)
      • Belmore Neidrauer Recognized by Benchmark Litigation Canada (5/1/2025 4:40:07 PM)
      • Belmore Neidrauer Shortlisted for Managing IP Awards 2025 (2/28/2025 10:57:23 PM)
      • Peter Wilcox (12/10/2024 7:10:08 PM)
      • Belmore Neidrauer Recognized by Best Law Firms™ - Canada (10/31/2024 4:55:17 PM)
      • Peter Wilcox awarded the Peter W. McBurney Memorial Award for Professional Excellence (10/1/2024 4:26:56 PM)
      • Chambers Canada Guide 2025 recognizes Belmore Neidrauer (9/27/2024 1:14:39 PM)
      • Belmore Neidrauer Recognized by Best Lawyers in Canada™ (8/29/2024 2:51:24 PM)
      • Managing IP recognizes Partners as 2024 Patent Stars (8/22/2024 3:37:26 PM)
      • Belmore Neidrauer Shortlisted for 2024 LMG Life Sciences Americas Awards (7/19/2024 2:28:19 PM)
      • IAM Patent 1000 recognizes Belmore Neidrauer LLP (6/5/2024 6:59:38 PM)
      • LEXPERT® recognizes Belmore Neidrauer as a Most Frequently Recommended Firm for Intellectual Property Litigation (3/7/2024 4:16:44 AM)
      • Belmore Neidrauer Shortlisted for Managing IP Awards 2024 (2/27/2024 7:46:55 PM)
      • Belmore Neidrauer secured another victory in the Federal Court of Appeal for our client Janssen. (2/16/2024 10:18:44 PM)
      • Belmore Neidrauer successfully represented Janssen on another appeal relating to infringement of Janssen’s patent covering INVEGA SUSTENNA® (1/26/2024 9:53:01 PM)
      • Belmore Neidrauer successfully represented Janssen in the Federal Court of Appeal on another appeal relating to INVEGA SUSTENNA® (1/24/2024 3:39:46 PM)
      • Belmore Neidrauer LLP Recognized by Legal 500 2024 (11/17/2023 4:46:20 PM)
      • Peter Wilcox recognized at the LMG Life Sciences Americas Awards (9/8/2023 4:00:00 PM)
      • LMG Life Sciences recognizes Belmore Neidrauer (9/8/2023 3:51:59 PM)
      • Peter Wilcox recognized in the Who’s Who Legal: IP 2023 Guide (8/18/2023 3:49:00 PM)
      • Belmore Neidrauer Shortlisted for LMG Life Sciences Awards Americas 2023 (8/9/2023 1:54:58 PM)
      • IAM Patent 1000 recognizes Belmore Neidrauer LLP (7/5/2023 8:58:24 PM)
      • Peter Wilcox recognized in Lexpert® Special Edition: Technology and Health 2023. (7/4/2023 4:00:00 AM)
      • Managing IP recognizes Belmore Neidrauer Partners as 2023 Patent Stars (6/9/2023 5:29:23 PM)
      • Benchmark Litigation Canada recognizes Belmore Neidrauer LLP (5/9/2023 5:43:41 PM)
      • Marian Wolanski to speak at CBA IP Day 2023 in Ottawa (4/24/2023 6:24:52 PM)
      • Peter Wilcox Shortlisted for Intellectual Property Litigator of the Year (4/11/2023 3:35:00 PM)
      • Belmore Neidrauer successfully represented Janssen in the Federal Court of Appeal in a decision relating to Janssen's patent covering INVEGA SUSTENNA® (4/11/2023 2:51:24 PM)
      • Lexpert recognizes Belmore Neidrauer as a Most Frequently Recommended firm for Intellectual Property Litigation (3/1/2023 5:00:00 AM)
      • LMG Life Sciences recognizes Belmore Neidrauer (10/5/2022 4:00:00 AM)
      • Belmore Neidrauer successfully represented Janssen in a patent trial affirming the validity of Janssen’s patent (8/31/2022 4:00:00 AM)
      • Belmore Neidrauer Shortlisted for LMG Life Sciences Americas Awards 2022 (8/3/2022 4:00:00 AM)
      • IAM Patent 1000 recognizes Belmore Neidrauer (7/4/2022 4:00:00 AM)
      • Managing IP recognizes Belmore Neidrauer Partners as 2022 Patent Stars (6/16/2022 4:00:00 AM)
      • Lexpert recognizes Marian Wolanski and Peter Wilcox in 2022 Lexpert Special Edition: Technology and Health Sciences (6/16/2022 4:00:00 AM)
      • LEXPERT® Recognizes Belmore Neidrauer as a leading Intellectual Property Litigation Firm (2/10/2022 5:00:00 AM)
      • Belmore Neidrauer Recognized by Chambers Canada 2022 as a Leading Canadian Intellectual Property Litigation firm (2/9/2022 5:00:00 AM)
      • Belmore Neidrauer successfully represented Janssen in two summary trials in the Federal Court (2/9/2022 5:00:00 AM)
      • Peter Wilcox recognized as a Global Elite 2022 Thought Leader by Who’s Who Legal (1/1/2022 5:00:00 AM)
      • Belmore Neidrauer recognized as one of Canada’s Best Law Firms 2022 by the Globe and Mail (11/16/2021 5:00:00 AM)
      • Legal 500 Canada 2021 Rankings Recognize Belmore Neidrauer LLP (11/12/2020 5:00:00 AM)
      • IP Stars 2020 Recognizes Belmore Neidrauer LLP (10/16/2020 4:00:00 AM)
      • Belmore Neidrauer LLP Recognized by Chambers Canada 2021 (9/9/2020 4:00:00 AM)
      • Peter Wilcox Recognized by Best Lawyers in Canada 2020 (10/1/2019 4:00:00 AM)
      • Belmore Neidrauer Recognized at the LMG Life Sciences Awards 2019 (9/19/2019 4:00:00 AM)
      • Belmore Neidrauer Named Patent Contentious Firm of the Year - Canada 2019 (4/5/2019 4:00:00 AM)
      • Peter Wilcox recognized by Chambers Global 2019 (2/25/2019 5:00:00 AM)
      • Peter Wilcox recognized by Best Lawyers in Canada 2019 (12/12/2018 5:00:00 AM)
      • Peter Wilcox recognized as a leading lawyer in the 2019 Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada (12/12/2018 5:00:00 AM)
      • IAM Patent 1000 Recognizes Belmore Neidrauer as a leading patent litigation firm (9/20/2018 4:00:00 AM)
      • Peter Wilcox Invited to be Fellow of Litigation Counsel of America (9/20/2018 4:00:00 AM)
      • Lexpert Recognizes Belmore Neidrauer as a Leading Firm in Litigation - Intellectual Property (9/18/2018 4:00:00 AM)
      • Managing IP Recognizes Belmore Neidrauer in its IP Stars Firm Survey 2018 (9/18/2018 4:00:00 AM)
      • Marian Wolanski Awarded Canadian Rising Star of the Year at the 2018 LMG Life Sciences Awards (9/18/2018 4:00:00 AM)
      • Peter Wilcox Recognized by Chambers Canada 2017 for Excellence in Intellectual Property Litigation (10/11/2017 4:00:00 AM)
      • Belmore Neidrauer wins Canada Patent Contentious Firm of the Year and Case of the Year Awards (3/27/2017 4:00:00 AM)
      • Peter Wilcox listed in WIPR Leaders Directory (3/2/2017 5:00:00 AM)
      • New Belmore Neidrauer LLP Partner – Marian Wolanski (2/1/2017 5:00:00 AM)
      • Peter Wilcox listed in the 2017 Lexpert American Lawyer Guide to the Leading 500 Lawyers in Canada (1/20/2017 5:00:00 AM)
      • Peter Wilcox listed in the 2016 Lexpert US/Canada Cross-Border Guide - Litigation (1/20/2017 5:00:00 AM)
      • Belmore Neidrauer wins Canadian Patent Contentious Firm of the Year at LMG Life Sciences Awards (9/16/2016 4:00:00 AM)
      • Belmore Neidrauer LLP recognized in Managing Intellectual Property's IP Stars Handbook (9/13/2016 4:00:00 AM)
      • LEXPERT® Recognizes Peter Wilcox (6/24/2016 4:00:00 AM)
      • Belmore Neidrauer LLP Recognized Again by IAM Patent 1000: The World's Leading Patent Professionals 2016 (5/30/2016 4:00:00 AM)
      • Belmore Neidrauer LLP Ranked in Managing Intellectual Property Magazine (3/7/2016 5:00:00 AM)
      • Chambers Canada recognizes Peter Wilcox in 2016 (1/4/2016 5:00:00 AM)
      • Peter Wilcox recognized by Best Lawyers in Canada 2016 (8/24/2015 4:00:00 AM)
      • Belmore Neidrauer LLP is listed in the Silver Band of 2015 edition of IAM Patent 1000 (6/30/2015 4:00:00 AM)
      • Peter Wilcox has been recognized by Who’s Who Legal 2015 (6/30/2015 4:00:00 AM)
      • Peter Wilcox is recognised by Chambers & Partners 2015 (5/7/2015 4:00:00 AM)
      • Benchmark Canada lists Belmore Neidrauer LLP as a "Recommended" Litigation Firm (5/5/2015 4:00:00 AM)
      • Who's Who Legal Life Sciences recognizes Peter Wilcox (12/22/2014 5:00:00 AM)
    • Awards
    • Diversity, Equity and Inclusion
    • Contact
  • Team
    • Anna Hucman
    • Andrew Medico
    • Mary Mutchler
    • Megan Pocalyuko
    • Marian Wolanski
  • Cases
    • Alexion Pharmaceuticals v Amgen Canada
    • Samsung Bioepis Co. Ltd. v Janssen Biotech, Inc.
    • Janssen Inc. v Apotex
    • Pharmascience v. Janssen
    • Janssen Inc. v JAMP
    • Janssen Inc. v Pharmascience Inc.
    • Janssen Inc. v Apotex Inc.
    • Janssen v. Pharmascience
    • Janssen Inc. v Apotex Inc.
    • Janssen Inc. et al v. Teva Canada Limited
    • Janssen v. Apotex
    • Janssen v. Apotex
    • Janssen v. Dr. Reddy
    • Janssen v. Pharmascience
    • Alexion v. Attorney General of Canada
    • Apotex Inc. v Janssen Inc. et al
    • Janssen v. Pharmascience
    • Janssen v Apotex
    • Janssen v Pharmascience
    • Janssen v Apotex, Pharmascience and Dr. Reddy’s Laboratories
    • Seedlings v. Pfizer
    • Eli Lilly Canada Inc. et al v. Apotex Inc.
    • Apotex v. Janssen
    • Elea v Simplot
    • Seedlings Life Sciences v Pfizer
    • Janssen Inc. et al v Teva Canada Limited
    • Janssen Inc. et al v Apotex Inc.
    • AbbVie Corporation et al v Samsung Bioepis Co. Ltd.
    • Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al.
    • Teva Canada Limited v. Janssen Inc.
    • Apotex Inc. v. Bayer Inc.
    • Janssen Inc. et al. v. Actavis Pharma Company et al.
    • Actavis Pharma Company v Alcon Canada Inc. et al
    • Bayer Inc. v. Apotex Inc. and Cobalt Pharmaceuticals Company
    • Pfizer Canada Inc. v. Teva Canada Limited
    • Bayer Inc. et al. v Fresenius Kabi Canada Ltd. et al.
    • Actavis Pharma Company v. Alcon Canada Inc.
    • Sanofi-Aventis Canada Inc. v. Eli Lilly Canada Inc.
    • Cobalt Pharmaceuticals Company v. Bayer Inc.
    • Takeda v. Apotex
    • Janssen Inc. v. Abbvie Corporation
    • Alcon Canada Inc. v. Cobalt Pharmaceuticals Company
    • Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Apotex Inc. and the Minister of Health
    • Teva Canada Limited v. Pfizer Canada Inc.
    • Alcon Canada Inc. v. Cobalt Pharmaceuticals Company - 2014 FC 149
    • Apotex Inc. v. Takeda Canada Inc.
    • Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Cobalt Pharmaceuticals Company and the Minister of Health
    • Varco Canada Limited v. Pason Systems Corp.
    • Alcon Canada Inc. v. Apotex Inc.
    • Janssen-Ortho Inc. v. Canada (Health)
    • Nicholas v. Environmental Systems (International) Limited
    • GlaxoSmithKline Inc. v. Pharmascience Inc.
    • Pfizer Canada Inc. v. Novopharm Limited
    • Pfizer Canada Inc. v. Apotex Inc.
    • Apotex Inc. v. Sanofi-Synthelabo Canada Inc.
    • Lotech Medical Systems Limited v. Kinetic Concepts Inc.
    • Pfizer Canada Inc. v. Canada (Health) - 2008 FCA 108
    • Pfizer Canada Inc. v. Canada (Health) - 2007 FC 649
    • Pfizer Canada Inc. v. Canada (Health) - 2007 FC 898
    • Pfizer Canada Inc. v. Canada (Minister of Health)
  • IP Insights
    • POP GOES THE TRADEMARK: POP MART SECURES TRADEMARK EXPUNGEMENT OF COMPETITOR MARK FOR NON-DISTINCTIVNESS, CONFUSION, AND BAD FAITH (6/19/2026 4:00:00 AM)
    • Misuse of Copyright or Misuse of Court Resources: Federal Court Upholds CMJ Order Allowing Misuse of Copyright Defence and Barring Plaintiff’s Arguments Against Viability on the Grounds of Issue Estoppel and Abuse of Process (6/12/2026 4:00:00 AM)
    • Too Little, Too Late: When A Letters Rogatory Motion Falls Short (6/8/2026 4:00:00 AM)
    • Words Matter: The Battle Over the Exact Meaning of an Undertaking (4/22/2026 3:30:23 PM)
    • WHEN THE CHIPS ARE DOWN: Federal Court of Appeal Dismisses McCain’s French Fry Process Patent Appeal (4/14/2026 4:00:00 AM)
    • UNSUBSCRIBED: Federal Court of Appeal Overturns Lower Court’s Judgment Issuing Declarations in News Subscription Summary Judgment (3/19/2026 4:00:00 AM)
    • WORKING (OUTSIDE) 9 TO 5: Employer’s Appeal in Respect of Copyright Ownership Dispute Dismissed (3/19/2026 4:00:00 AM)
    • LOSING TRACTION: Truck Accessory Company’s Bid for Confidential Information Interlocutory Injunctions Rejected (3/13/2026 4:00:00 AM)
    • Class Dismissed: Fothergill Fact-Checks Motion to Certify a Proposed Class Action Alleging Canadian Generic Drug Price Fixing Conspiracy (2/20/2026 5:00:00 AM)
    • MONEY DOESN’T GROW ON TREES: Federal Court Dismisses GreenBlue’s Purported Expenses in Accounting of Profits Analysis (1/28/2026 5:00:00 AM)
    • MAMMA MIA, LET THE CLAIM GO: Copyright Claim Respecting Queen Music Videos Struck with Leave to Amend (1/14/2026 5:00:00 AM)
    • The High Price of Brand Piggybacking: Exxon Mobil Secures $275,000 Default Judgment in Trademark Battle (12/17/2025 5:54:23 PM)
    • Why a Single Letter Can Cost You Your Brand: Fruiticana vs. Fruitocana (12/17/2025 5:00:00 AM)
    • CONSTRUCTING A PROPER STATEMENT OF CLAIM: Federal Court Strikes Statement of Claim in The Construction Specifications Institute, Inc. (11/26/2025 5:00:00 AM)
    • For The First Time In Canada, the Federal Court Finds Infringement by Common Design (11/14/2025 6:48:22 PM)
    • Cards on the Table: Examining the Patentability of Poker Method Claims (11/12/2025 5:00:00 AM)
    • Ontario Court Confirms Authority Over Challenges to AI Content Use (11/7/2025 5:00:00 AM)
    • The Devil’s in the Details: Norwich Orders Denied Against Internet Service Providers (10/31/2025 4:00:00 AM)
Belmore Neidrauer LLP White Logo
  • Belmore Neidrauer LLP
    TD North Tower, 77 King Street West, Suite 4020 
    PO Box 16, TD Centre, Toronto, ON,  M5K 1A1
    • p.(416) 863-1771
    • f.(416) 863-9171
    • e.info@belmorelaw.com
  • About
  • Team
  • Cases
  • Privacy Policy
  • Join us on LinkedIn

© 2023 Belmore Neidrauer LLP | Legal Disclaimer

Law Firm Marketing | Cubicle Fugitive